OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site
Zhiqing Liu, Yi Li, Haiying Chen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2388-2408
Open Access | Times Cited: 38
Zhiqing Liu, Yi Li, Haiying Chen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2388-2408
Open Access | Times Cited: 38
Showing 26-50 of 38 citing articles:
Discovery of 1H-Imidazo[4,5-b]pyridine Derivatives as Potent and Selective BET Inhibitors for the Management of Neuropathic Pain
Xuetao Chen, Danyan Cao, Chihong Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8725-8744
Closed Access | Times Cited: 6
Xuetao Chen, Danyan Cao, Chihong Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8725-8744
Closed Access | Times Cited: 6
Inhibition of BET Family Proteins Suppresses African Swine Fever Virus Infection
Yaru Zhao, Qingli Niu, Saixia Yang, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 9
Yaru Zhao, Qingli Niu, Saixia Yang, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 9
Rational design, synthesis and biological evaluation of benzo[d]isoxazole derivatives as potent BET bivalent inhibitors for potential treatment of prostate cancer
Junhua Li, Run Zhu, Xiaoxi Zhuang, et al.
Bioorganic Chemistry (2023) Vol. 135, pp. 106495-106495
Closed Access | Times Cited: 4
Junhua Li, Run Zhu, Xiaoxi Zhuang, et al.
Bioorganic Chemistry (2023) Vol. 135, pp. 106495-106495
Closed Access | Times Cited: 4
Targeting bromodomian-containing protein 8 (BRD8): An advanced tool to interrogate BRD8
Tingting Wu, Yali Chen, Qidong You, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116271-116271
Closed Access | Times Cited: 1
Tingting Wu, Yali Chen, Qidong You, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116271-116271
Closed Access | Times Cited: 1
BRD4 as an emerging epigenetic therapeutic target for inflammatory bowel disease
Zonghui Ma, Andrew A. Bolinger, Irina V. Pinchuk, et al.
Advances in pharmacology (2024), pp. 203-236
Closed Access | Times Cited: 1
Zonghui Ma, Andrew A. Bolinger, Irina V. Pinchuk, et al.
Advances in pharmacology (2024), pp. 203-236
Closed Access | Times Cited: 1
Discovery of 4,5-dihydro-benzo[g]indazole-based hydroxamic acids as HDAC3/BRD4 dual inhibitors and anti-tumor agents
Bo Li, Yibing Chen, Siyuan Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 285, pp. 117230-117230
Closed Access | Times Cited: 1
Bo Li, Yibing Chen, Siyuan Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 285, pp. 117230-117230
Closed Access | Times Cited: 1
Molecular Dynamics Simulations Combined with Markov Model to Explore the Effect of Allosteric Inhibitor Binding on Bromodomain-Containing Protein 4
Xiaotang Yang, Yilin Gao, Fuyan Cao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10831-10831
Open Access | Times Cited: 3
Xiaotang Yang, Yilin Gao, Fuyan Cao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10831-10831
Open Access | Times Cited: 3
CBP/p300 bromodomain: new promising epigenetic target
Qiuping Xiang, Yang Zhou, Yan Zhang, et al.
Visualized Cancer Medicine (2022) Vol. 3, pp. 3-3
Open Access | Times Cited: 4
Qiuping Xiang, Yang Zhou, Yan Zhang, et al.
Visualized Cancer Medicine (2022) Vol. 3, pp. 3-3
Open Access | Times Cited: 4
1,4‐Dihydropyridinebutyrolactone‐derived ring‐opened ester and amide analogs targeting BET bromodomains
Jiewei Jiang, Pei‐Liang Zhao, Logan H. Sigua, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 11
Open Access | Times Cited: 3
Jiewei Jiang, Pei‐Liang Zhao, Logan H. Sigua, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 11
Open Access | Times Cited: 3
Marine natural product-inspired discovery of novel BRD4 inhibitors with anti-inflammatory activity
Shuxia Chen, Jichen Yang, Xiangyu Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117193-117193
Closed Access
Shuxia Chen, Jichen Yang, Xiangyu Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117193-117193
Closed Access
BRD4 as a potential target for human papillomaviruses associated cancer
Abdul Qawee Rani, Srinivasa Reddy Bonam, Jia Zhou, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 12
Open Access | Times Cited: 1
Abdul Qawee Rani, Srinivasa Reddy Bonam, Jia Zhou, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 12
Open Access | Times Cited: 1
Conditional Human BRD4 Knock-In Transgenic Mouse Genotyping and Protein Isoform Detection
Michael Paul Lewis, Shwu-Yuan Wu, Cheng‐Ming Chiang
BIO-PROTOCOL (2022) Vol. 12, Iss. 7
Open Access | Times Cited: 1
Michael Paul Lewis, Shwu-Yuan Wu, Cheng‐Ming Chiang
BIO-PROTOCOL (2022) Vol. 12, Iss. 7
Open Access | Times Cited: 1
Structural and biochemical insights into purine-based drug molecules in hBRD2 delineate a unique binding mode opening new vistas in the design of inhibitors of the BET family
Aishwarya H. Arole, Prashant Deshmukh, Ashok Sridhar, et al.
Acta Crystallographica Section D Structural Biology (2023) Vol. 79, Iss. 8, pp. 758-774
Closed Access
Aishwarya H. Arole, Prashant Deshmukh, Ashok Sridhar, et al.
Acta Crystallographica Section D Structural Biology (2023) Vol. 79, Iss. 8, pp. 758-774
Closed Access
